SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bajaj Healthcare - Quaterly Results

30 May 2023 Evaluate
The sales slipped to Rs. 1584.44 millions for the March 2023 quarter as against Rs. 1757.14 millions during the year-ago period.The company suffered a huge decline of -79.44% to Rs. 35.92  millions from Rs. 174.73 millions  of corresponding previous quarter.Operating profit for the quarter ended March 2023 decreased to 197.84 millions as compared to 256.55 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1584.44 1757.14 -9.83 6732.92 6798.89 -0.97 6732.92 6798.89 -0.97
Other Income 7.24 4.48 61.61 15.98 14.44 10.66 15.98 14.44 10.66
PBIDT 197.84 256.55 -22.88 1084.44 1199.45 -9.59 1084.44 1199.45 -9.59
Interest 73.60 44.86 64.07 228.72 126.24 81.18 228.72 126.24 81.18
PBDT 124.24 211.69 -41.31 855.72 1073.21 -20.27 855.72 1073.21 -20.27
Depreciation 74.22 42.39 75.09 273.55 176.36 55.11 273.55 176.36 55.11
PBT 50.02 169.30 -70.45 582.17 896.85 -35.09 582.17 896.85 -35.09
TAX 14.10 -5.43 -359.67 151.92 182.98 -16.97 151.92 182.98 -16.97
Deferred Tax -8.78 -7.85 11.85 -11.66 -6.14 89.90 -11.66 -6.14 89.90
PAT 35.92 174.73 -79.44 430.25 713.87 -39.73 430.25 713.87 -39.73
Equity 137.99 137.99 0.00 137.99 137.99 0.00 137.99 137.99 0.00
PBIDTM(%) 12.49 14.60 -14.48 16.11 17.64 -8.70 16.11 17.64 -8.70

Bajaj Healthcare Share Price

348.95 -1.50 (-0.43%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×